Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters

Clinical and Vaccine Immunology

Volumn 21, Issue 4, 2014, Pages 546-551

  Humphryes, P C ^a   Weeks, M E ^b   AbuOun, M ^a   Thomson, G ^a   Nunez A ^a   Coldham, N G ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN LIPL32; RECOMBINANT PROTEIN; BACTERIAL VACCINE; LIPL32 PROTEIN, LEPTOSPIRA; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PURIFICATION; ESCHERICHIA COLI; FEMALE; HAMSTER; HISTOPATHOLOGY; KIDNEY INFECTION; LEPTOSPIRA INTERROGANS; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; SPECIES INVASION; SURVIVAL RATE; VACCINATION; VIRUS STRAIN; ANIMAL; BACTERIAL LOAD; CYTOCHEMISTRY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; KIDNEY; LEPTOSPIROSIS; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SURVIVAL;

ANIMALS; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CRICETINAE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HISTOCYTOCHEMISTRY; KIDNEY; LEPTOSPIRA INTERROGANS SEROVAR CANICOLA; LEPTOSPIROSIS; LIPOPROTEINS; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, SYNTHETIC;

EID: 84897953140     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00719-13     Document Type: Article

References (25)

1. Adler B, de la Pena Moctezuma A. 2010. Leptospira and leptospirosis. Vet. Microbiol. 140:287-296. http://dx.doi.org/10.1016/j.vetmic.2009.03.012.
2. Woodward MJ. 2001. Leptospira, p 2137-2158. In Sussman M (ed), Molecular medical microbiology. Academic Press, San Diego, CA.
3. Adler B, Lo M, Seemann T, Murray GL. 2011. Pathogenesis of leptospirosis: the influence of genomics. Vet. Microbiol. 153:73-81. http://dx.doi.org/10. 1016/j.vetmic.2011.02.055.
4. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, Peru-United States Leptospirosis Consortium. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3:757-771. http://dx.doi.org/10.1016/S1473-3099(03)00830-2. (Pubitemid 37489960)
5. Collins RA. 2006. Leptospirosis. Biomed. Sci. 50:116-117, 119-121.
6. Levett PN. 2001. Leptospirosis. Clin. Microbiol. Rev. 14:296-326. http://dx.doi.org/10.1128/CMR.14.2.296-326.2001. (Pubitemid 32294672)
7. Department for Environment, Food and Rural Affairs. 2008. Zoonoses report. Defra Publications, London, United Kingdom.
8. Koizumi N, Watanabe H. 2005. Leptospirosis vaccines: past, present, and future. J. Postgrad. Med. 51:210-214. (Pubitemid 41782218)
9. Klaasen HL, Molkenboer MJ, Vrijenhoek MP, Kaashoek MJ. 2003. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet. Microbiol. 95:121-132. http://dx.doi.org/10.1016/S0378-1135(03) 00152-4. (Pubitemid 36829324)
10. Dong H, Hu Y, Xue F, Sun D, Ojcius DM, Mao Y, Yan J. 2008. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein.BMCMicrobiol. 8:223. http://dx.doi.org/10.1186/1471-2180-8-223.
11. Cullen PA, Xu X, Matsunaga J, Sanchez Y, Ko AI, Haake DA, Adler B. 2005. Surfaceome of Leptospira spp. Infect. Immun. 73:4853-4863. http://dx.doi.org/10. 1128/IAI.73.8.4853-4863.2005.
12. Wang Z, Jin L, Wegrzyn A. 2007. Leptospirosis vaccines. Microb. Cell Fact. 6:39. http://dx.doi.org/10.1186/1475-2859-6-39.
13. Seixas FK, Fernandes CH, Hartwig DD, Conceicao FR, Aleixo JA, Dellagostin OA. 2007. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can. J. Microbiol. 53:472-479. http://dx.doi.org/10.1139/w06-138. (Pubitemid 47028512)
14. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA. 1999. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect. Immun. 67:6572-6582.
15. Hauk P, Barbosa AS, Ho PL, Farah CS. 2012. Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J. Biol. Chem. 287:4826-4834. http://dx.doi.org/10.1074/jbc.M111.277210.
16. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, Andre-Fontaine G. 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect. Immun. 73:4062-4069. http://dx.doi.org/10.1128/IAI.73.7.4062- 4069.2005. (Pubitemid 40923146)
17. Humphryes PC, Weeks ME, Gielbert A, Thomson G, Coldham NG. 2012. Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency. Clin. Vaccine Immunol. 19:587-593. http://dx.doi.org/10.1128/CVI.05622-11.
18. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, Matsunaga J, Levett PN, Bolin CA. 2000. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect. Immun. 68:2276-2285. http://dx.doi.org/10.1128/IAI.68.4.2276-2285.2000. (Pubitemid 30164865)
19. Bancroft JD, Stevens AL. 1996. Theory and practice of histological techniques, 4th ed. Churchill Livingstone, Edinburgh, Scotland.
20. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF. 2006. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect. Immun. 74:1745-1750. http://dx.doi.org/10.1128/IAI.74.3.1745-1750.2006. (Pubitemid 43346809)
21. Grassmann AA, Felix SR, Ximendes Dos Santos C, Amaral MG, Seixas Neto AC, Fagundes MQ, Seixas FK, Da Silva EF, Conceicao FR, Dellagostin OA. 2012. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin. Vaccine Immunol. 19:740-745. http://dx.doi.org/10.1128/CVI.05720-11.
22. Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Kayhty H. 1996. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 348:1688-1692. http://dx.doi.org/10.1016/S0140-6736(96)04356-5. (Pubitemid 27007531)
23. Seixas FK, Da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, Dossa RG, Dellagostin OA. 2007. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88-95. http://dx.doi.org/10.1016/j.vaccine.2007.10.052. (Pubitemid 350213201)
24. Cao Y, Faisal SM, Yan W, Chang YC, McDonough SP, Zhang N, Akey BL, Chang YF. 2011. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model. Vaccine 29:7379-7386. http://dx.doi.org/10.1016/j.vaccine.2011.07.070.
25. Lucas DS, Cullen PA, Lo M, Srikram A, Sermswan RW, Adler B. 2011. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29:3413-3418. http://dx.doi.org/10.1016/j.vaccine.2011.02.084.